IBD & Intestinal Disorders
News
JAK inhibitors may increase risk of herpes zoster
Patients who received Janus kinase (JAK) inhibitors had a 57% increased relative risk of herpes zoster infection.
Conference Coverage
FMT appears safe and effective for IBD patients with recurrent C. difficile
Most patients were cured of C. difficile after one fecal transplant.
News
SECURE-IBD registry traces COVID-19 in patients with Crohn’s, colitis
Gastroenterologists and other clinicians caring for patients with IBD are being encouraged to report outcomes for pediatric and adult patients...
News
Potential GI manifestation, transmission of coronavirus
The virus appears to infect and could potentially spread through the gastrointestinal route.
Conference Coverage
Probably okay to skip SIBO breath test before starting rifaximin in IBS-D
MAUI, HAWAII – You can’t trust the results.
Conference Coverage
IBD quality initiative slashes ED utilization
A quality initiative led to sharp drops in emergency department visits, hospitalizations, and opioid use for Crohn’s and ulcerative colitis...
News
Biopsy not required to diagnose most cases of pediatric celiac disease
An updated guidance from the European Society of Pediatric Gastroenterology, Hepatology, and Nutrition could facilitate diagnosis and reduce...
Conference Coverage
Can diet, microbiome personalization reverse IBD increase?
AUSTIN, TEX. – Personalization of treatments with improved diet and microbial manipulations could reverse the rising incidence of inflammatory...
News
FDA strengthens warning regarding clozapine, serious bowel complication risk
Clozapine affects bowel function in a majority of patients, and constipation is a common adverse event associated with clozapine use.
News
FDA approves fidaxomicin for treatment of C. difficile–associated diarrhea in kids
Approval was based on results from SUNSHINE, a phase 3, multicenter, investigator-blind, randomized, parallel-group study in 142 pediatric...